Deerfield Management leads $40 million funding round for Baltimore's Dracen Pharmaceuticals - Baltimore Business Journal

New York-based investment firm Deerfield Management is leading a $40 million Series A funding round for Baltimore's Dracen Pharmaceuticals Inc.